Global adoption of TTTS ultrasound treatment exceeds 50% by 2028
Resolves: At least 50% of TTTS cases treated worldwide use the non-invasive high-powered ultrasound method as their primary intervention.
user-generated· adoption
Global adoption of TTTS ultrasound treatment exceeds 50% by 2028
Market overview
Within two years of FDA approval, over half of eligible TTTS cases globally will opt for the non-invasive ultrasound treatment due to its reduced risk and recovery time compared to traditional methods.
adoption prediction market
- Implied probability (Yes)
- 60%
- Closes
- 2028-12-31
About this prediction
Resolution criteria
At least 50% of TTTS cases treated worldwide use the non-invasive high-powered ultrasound method as their primary intervention.
Source: user-generated
More adoption markets
- European AI model startup raises $500M+ by end of 2026 — 60% Yes
- Owen Cooper's career accelerates with leading film role within 12 months — 68% Yes
- Anthropic joins SynthID watermarking program within 12 months — 60% Yes
- Forge Global and Sydecar to lose 20% of trading volume by August 2026 — 70% Yes
- Gotham FC's average home attendance increases by 20% in 2028 season — 75% Yes
- Chainalysis raises $200M by Q1 2027 following event — 55% Yes
- Wispr daily active users exceed 5 million by 2026-12-31 — 70% Yes
- Commodity trading firms shift 20% of Asia-Pacific gold orders to Hong Kong by 2027 — 60% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…